Ilaria Rambaldi

Area of research

Radiology, Nuclear Medicine and Imaging · Hematology

Research interest

Research focused on Positron emission tomography and Nuclear medicine, with related work in Neuroendocrine tumors, Prostate cancer, Multiple myeloma. Notable publications include '18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease', '18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study', and 'Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial...'.

Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study

Frontiers in Medicine 2026cited by 0position: middledoi

Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT

Diagnostics 2023cited by 5position: middledoi

The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer

Cancers 2022cited by 21position: middledoi

Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review

Endocrine 2022cited by 12position: middledoi

Diagnostic Contribution of Contrast-Enhanced CT as Compared with Unenhanced Low-Dose CT in PET/CT Staging and Treatment Response Assessment of<sup>18</sup>F-FDG–Avid Lymphomas: A Prospective Study

Journal of Nuclear Medicine 2021cited by 5position: middledoi

Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021cited by 5position: middledoi

10-Year Clinical Experience With 18F-Choline PET/CT

Clinical Nuclear Medicine 2020cited by 6position: middledoi

18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study

Cancers 2019cited by 30position: middledoi

Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study

Abdominal Radiology 2018cited by 30position: middledoi

Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia 2018cited by 20position: middledoi

Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations

Current Radiopharmaceuticals 2018cited by 4position: middledoi

PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY

The Journal of Urology 2017cited by 0position: middledoi

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

Leukemia 2015cited by 143position: middledoi

Recent publications

Grants

Frequent collaborators